Dr. William Martin Carrera, MD

Dr. Carrera practices at East Bay Retina Consultants, Inc. in Oakland, California.

Dr. Carrera's NPI, 1679014013, was assigned on March 18, 2017. Dr. Carrera graduated from Cleveland Medical College, Homeopathic in 2017. Dr. Carrera holds California license A158123.

Dr. Carrera's primary practice is East Bay Retina Consultants, Inc., at 3300 Telegraph Ave, Oakland, CA 94609-3028. The practice phone is (510) 444-1600.

Dr. Carrera's primary practice is East Bay Retina Consultants, Inc. in Oakland, California. Dr. Carrera is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. Dmand AI also links Dr. Carrera to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carrera practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Carrera's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Carrera is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Carrera's licenses on file in 3 states: California, Massachusetts and North Carolina.

Dmand AI lists cataract, dry eye, laser destruction of retinal or choroid lesions, retinal detachment, secondary membranaous cataract surgery, surgical retina and vitreous procedures, vision problems and vitreous eye degeneration among the conditions Dr. Carrera treats.

CMS data shows 1,278 Medicare services from Dr. Carrera across 15 procedure codes in 2024, for 404 Medicare patients. Medicare paid $118,422 for them.

CMS counts 404 Medicare patients who saw Dr. Carrera in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carrera's median patient age at 67, with 53% women.

In 2024, Dr. Carrera wrote 190 Medicare Part D claims for 76 patients. 51% of them were for generic drugs. CMS names the drug for 138 of them, across 7 drugs with 11 or more claims each, at $14,422 in total drug cost. In 2023, CMS named 293 claims across 7 drugs.

Dr. Carrera accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Carrera, published from 2010 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Visual Acuity, Tomography, Optical Coherence and Retinal Diseases. Dr. Carrera has published most often in Retin Cases Brief Rep. Dr. Carrera's most frequent co-authors are Caleb Chin Tao Ng, Anita Agarwal, MD and Robert N. Johnson, MD.

Dmand AI links Dr. Carrera to 12 clinical trials, 8 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Geographic Atrophy, Vision, Low and Macular Degeneration. Hoffmann-La Roche sponsors the most, 3.

CMS Open Payments shows 30 general payments to Dr. Carrera from 8 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 67% of the total. Genentech, Inc. paid the most, $6,862.

Dr. Carrera graduated from Cleveland Medical College, Homeopathic in 2017.

Dr. Carrera is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.